Literature DB >> 16195775

Small-cell lung cancer presenting as diabetes insipidus and Cushing's syndrome.

Amar Agha1, Sinead Brennan, Kevin B Moore, Liam Grogan, Christopher J Thompson.   

Abstract

Small-cell lung cancer presenting with a combination of cranial diabetes insipidus and Cushing's syndrome secondary to ectopic adrenocorticotropin (ACTH) secretion is very rare and has only been described previously in one case report Our patient was a 49 year old man, in whom the initial presenting features of small-cell lung cancer were cranial diabetes insipidus secondary to pituitary metastases and severe hypokalaemia resulting from ectopic ACTH hormone secretion. This case is a remarkable example of the complex metabolic endocrine manifestations of small-cell lung cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16195775     DOI: 10.1007/s11102-005-3308-1

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  8 in total

1.  Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism.

Authors:  F Vignati; P Loli
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

Review 2.  Postoperative diabetes insipidus.

Authors:  J Seckl; D Dunger
Journal:  BMJ       Date:  1989-01-07

3.  Clinicopathologic review of 88 cases of carcinoma metastatic to the putuitary gland.

Authors:  R J Teears; E M Silverman
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

4.  Central diabetes insipidus and Cushing's syndrome due to ectopic ACTH production by disseminated small cell lung cancer: a case report.

Authors:  M Castro Cabezas; D H Vrinten; J A Burgers; R J Croughs
Journal:  Neth J Med       Date:  1998-07       Impact factor: 1.422

5.  Endocrine function in small cell undifferentiated carcinoma of the lung.

Authors:  P K Bondy; E D Gilby
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

6.  Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma.

Authors:  M B Max; M D Deck; D A Rottenberg
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

7.  Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer.

Authors:  F A Shepherd; J Laskey; W K Evans; P E Goss; E Johansen; F Khamsi
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

8.  Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production.

Authors:  E W Winquist; J Laskey; M Crump; F Khamsi; F A Shepherd
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

  8 in total
  2 in total

1.  Glucose metabolism disorders in cancer patients in a Chinese population.

Authors:  Ya-Shi Zhan; Lie Feng; Shao-Hui Tang; Wan-Geng Li; Meng Xu; Tian-Fu Liu; You-Fen Zhou; Yu-Lin Ma; Yun Zhang; Xian-Ming Pu
Journal:  Med Oncol       Date:  2009-03-05       Impact factor: 3.064

2.  Case report of severe Cushing's syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol concentration.

Authors:  Muhammad M Hammami; Najla Duaiji; Ghazi Mutairi; Sabah Aklabi; Nasser Qattan; Mohei El-Din M Abouzied; Mohamed W Sous
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.